ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature

被引:55
作者
Eder, Matthias [1 ]
Krivoshein, Arcadius V. [2 ]
Backer, Marina [2 ]
Backer, Joseph M. [2 ]
Haberkorn, Uwe [3 ]
Eisenhut, Michael [1 ]
机构
[1] German Canc Res Ctr, D-69120 Heidelberg, Germany
[2] SibTech Inc, Brookfield, CT 06804 USA
[3] Heidelberg Univ, Dept Nucl Med, D-69120 Heidelberg, Germany
关键词
Ga-68; PET imaging; VEGFR-2; HBED-CC; NOTA; ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; SITE; PEPTIDES; BIOLOGY; TRACER; GA-68; CELLS; TAG;
D O I
10.1016/j.nucmedbio.2010.02.001
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: VEGF receptors play a key role in angiogenesis and are important targets for several approved and many experimental drugs. Imaging of VEGF receptor expression in malignant tumors would provide important information, which can influence patient management. The aim of this study was the development of an easy-to-label positron-emitting tracer for imaging VEGF receptors. The tracer is based on engineered single-chain VEGF (scVEGF), expressed with cysteine-containing fusion tag (Cys-tag) for site-specific conjugation of PEGylated bifunctional chelating agents, HBED-CC or NOTA, suitable for labeling with Ga-68 at ambient temperature. Methods: scVEGF-PEG-HBED-CC was synthesized by activating a single carboxyl group of the [Fe(HBED-CC)](-) complex with N-hydroxysuccinimide. Reaction of the activated complex with NH2-PEG-maleimide was followed by site-specific conjugation of PEGylated chelator to a thiol group in Cys-tag of scVEGF. The scVEGF-PEG-NOTA conjugate was synthesized using NHS-PEG-maleimide and p-NH2-Bn-NOTA. Ga-68 complexation was performed in HEPES buffer (pH 4.2) at room temperature. The functional activity after labeling was tested by radioligand cell binding assays. Biodistribution and PET studies in tumor-bearing mice were performed after 1, 2, 3 and 4 11 postinjection. Results: The radiolabeling of'scVEGF-PEG-HBED-CC proved more efficient than scVEGF-PEG-NOTA allowing to stop the reaction after 4 min (>97% radiochemical yield). Radioligand cell binding assays performed on HEK-293 cells overexpressing VEGFR-2 revealed no change in the binding properties of Ga-68-radiolabeled scVEGF relative to other scVEGF-based tracers. Both tracers showed comparable results in biodistribution, such as tumor accumulation and low liver uptake. The tracers were stable in 50% human serum for at least 72 h. Conclusions: The conjugates scVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA revealed comparable in vivo characteristics and allowed easy-to-perform labeling with high stability for fast [Ga-68]PET imaging of VEGF receptors in angiogenic vasculature. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:405 / 412
页数:8
相关论文
共 35 条
[21]  
Li S, 2004, Q J NUCL MED MOL IM, V48, P198
[22]   Imaging gastrointestinal tumours using vascular endothelial growth factor-165 (VEGF165) receptor scintigraphy [J].
Li, S ;
Peck-Radosavljevic, M ;
Kienast, O ;
Preitfellner, J ;
Hamilton, G ;
Kurtaran, A ;
Pirich, C ;
Angelberger, P ;
Dudczak, R .
ANNALS OF ONCOLOGY, 2003, 14 (08) :1274-1277
[23]  
Li SR, 2001, INT J CANCER, V91, P789, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1126>3.0.CO
[24]  
2-K
[25]   Targeted in vivo labeling of receptors for vascular endothelial growth factor - Approach to identification of ischemic tissue [J].
Lu, EX ;
Wagner, WR ;
Schellenberger, U ;
Abraham, JA ;
Klibanov, AL ;
Woulfe, SR ;
Csikari, MM ;
Fischer, D ;
Schreiner, GF ;
Brandenburger, GH ;
Villanueva, FS .
CIRCULATION, 2003, 108 (01) :97-103
[26]   Targeting peptides and positron emission tomography [J].
Lundqvist, H ;
Tolmachev, V .
BIOPOLYMERS, 2002, 66 (06) :381-392
[27]  
Maecke HR, 2005, J NUCL MED, V46, p172S
[28]   Advances in the structural biology, VEGF-R kinase inhibitors for design and clinical development of the treatment of angiogenesis [J].
Manley, PW ;
Bold, G ;
Brüggen, J ;
Fendrich, G ;
Furet, P ;
Mestan, J ;
Schnell, C ;
Stolz, B ;
Meyer, T ;
Meyhack, B ;
Stark, W ;
Strauss, A ;
Wood, J .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1697 (1-2) :17-27
[29]   Imaging angiogenesis: Applications and potential for drug development [J].
Miller, JC ;
Pien, HH ;
Sahani, D ;
Sorensen, AG ;
Thrall, JH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (03) :172-187
[30]   In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft [J].
Nagengast, Wouter B. ;
de Vries, Elisabeth G. ;
Hospers, Geke A. ;
Mulder, Nanno H. ;
de Jong, Johan R. ;
Hollema, Harry ;
Brouwers, Adrienne H. ;
van Dongen, Guns A. ;
Perk, Lars R. ;
Lub-de Hooge, Marjolijn N. .
JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (08) :1313-1319